This analysis of data from a phase 1/2 study evaluates potential cases of isocitrate dehydrogenase differentiation syndrome among patients treated with enasidenib for relapsed/refractory acute myeloid leukemia.
http://ift.tt/2Due3to
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου